eMolecules and Optic Join Forces to Accelerate Drugs’ Time-to-Market

SAN FRANCISCO, Oct. 3, 2024 /PRNewswire/ — In a move to significantly accelerate AI-powered drug discovery, eMolecules, a leading chemical sourcing company, has partnered with Optic, a digital biology company with a mission to redefine drug discovery using the power of AI. This…